Jennifer K. Simpson - 07 Mar 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Director
Signature
/s/ Scott Tarriff, Attorney-in-Fact
Issuer symbol
EGRX
Transactions as of
07 Mar 2023
Transactions value $
$0
Form type
4
Filing time
09 Mar 2023, 20:02:57 UTC
Previous filing
01 Feb 2023
Next filing
29 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EGRX Stock Option (right to buy) Award $0 +16,253 $0.000000 16,253 07 Mar 2023 Common Stock 16,253 $26.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.